Nantahala Capital Management, LLC 13D/13G Filings for Grace Therapeutics, Inc. (GRCE)

Nantahala Capital Management, LLC 13D and 13G filings for Grace Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-05-15
4:46 pm
Purchase
2025-03-31 13G Grace Therapeutics, Inc.
GRCE
Nantahala Capital Management, LLC 1,391,773
9.990%
1,391,773increase
(New Position)
Filing